https://www.cliexa.com/wp-content/uploads/2016/04/cliexa_icon_c.png 439 439 Burak Cetin http://www.cliexa.com/wp-content/uploads/2018/08/hoover_1920x1080-300x169.png Burak Cetin2016-04-21 22:53:072018-09-12 01:28:11Bahri Bilir, MD quotes cliexa-IBD release in Apple Store
I am very excited to see Cliexa-IBD as a free application in iTunes store. This is going to provide a very important tool for patients with Crohn’s disease, to assess their disease activity, without any help from others. In addition, this tool gives them an on going monitoring during each and every different treatment. It will help them to remember what has worked and what has not worked in the past. If they are in remission and suddenly the disease becomes active ( as their scores start to rise) this application will allow early intervention in addition it will remind their healthcare providers, which of the medications should be chosen first, as the most effective therapy. This is so important in this illness, where each person has significant variability with activation and remissions. There is no “one medication for all that works in everybody.
It is true that this is a well validated healthcare index that is used by every single drug that is going for FDA approval. Despite of this, it is not widely used in physician offices because of time constraints. Cliexa-IBD app will overcome this problem as well.
There are other applications on the market including, the one which is developed by CCFA utilizing same validated score, CDAI. However in my mind what makes this application superior to others are the two factors that I mentioned above:
1. Ease of use by the patient
2. Ongoing dynamic nature of monitoring the activity of the disease. utilizing the score on time with the addition of the medications and their effect on the outcome, as soon as the patient starts using them.
So I guess the next step will be to receive the feedback from the patients who are actually using them and forwarding it to their healthcare providers. If successful, this is going to increase the patient adherence to the therapy, thus, facilitating to reach a successful outcome sooner.
Bahri Bilir MD FACP FAASLD
Rocky Mountain Gastroenterology Denver, Colorado
3513 Brighton Blvd, Suite 520
Denver, CO 80216